 | PRD_001109 | Name: | peptide ligand | Formula: | C35 H51 Cl N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_001111 | Name: | peptide ligand | Formula: | C35 H50 Cl2 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_001117 | Name: | Peptide aldehyde inhibitor Ac-NSFSQ-H | Formula: | C26 H39 N7 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_001118 | Name: | Peptide aldehyde inhibitor Ac-DSFDQ-H | Formula: | C27 H38 N6 O12 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000771 | Name: | Peptide aldehyde inhibitor Ac-NSTSQ-H | Formula: | C21 H37 N7 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000772 | Name: | Peptide aldehyde inhibitor Ac-ESTLQ-H | Formula: | C25 H44 N6 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000776 | Name: | Lyngbyastatin 7 | Formula: | C48 H66 N8 O12 | Definition date: | 2013-02-06 | Last modified: | 2013-06-03 |
|
 | PRD_000780 | Name: | PL-49 | Formula: | C36 H63 N9 O11 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
 | PRD_000786 | Name: | Peptide inhibitor (ACE)VDV(3PX)D-CHO | Formula: | C28 H47 N5 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000793 | Name: | ACE-AEIK-CHO ALDEHYDE peptide inhibitor | Formula: | C22 H41 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000794 | Name: | C6H5(CH2)8-derivatized peptide inhibitor | Formula: | C40 H63 N8 O11 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000807 | Name: | hydrocinnamoyl-derivatized PLHSpTA peptide | Formula: | C36 H55 N9 O12 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000808 | Name: | D-peptide inhibitor | Formula: | C70 H110 N19 O19 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000809 | Name: | LDPPLHSpTA phosphopeptide | Formula: | C44 H72 N12 O17 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000810 | Name: | 3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide | Formula: | C47 H67 N11 O16 P S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000816 | Name: | DIMERIC PEPTIDE INHIBITOR | Formula: | C78 H116 N21 O17 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000854 | Name: | DB6 peptide | Formula: | C57 H77 N13 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000855 | Name: | DB5 peptide | Formula: | C49 H74 N15 O10 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000892 | Name: | METHYL (2R)-1-[(6S,9S,12S,13S,17S,20S,23R)-9-(3-AMINO-3-OXOPROPYL)-12,23-DIBENZYL-13-HYDROXY-2,2,8,20,22-PENTAMETHYL-17-(2-METHYLPROPYL)-4,7,10,15,18,21,24-HEPTAOXO-6-(PROPAN-2-YL)-3-OXA-5,8,11,16,19,22-HEXAAZATETRACOSAN-24-YL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C52 H78 N8 O12 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
 | PRD_000915 | Name: | benzyl [(2S)-1-({(2R)-1-[(1S,2S)-2-{[(2R,3S,4S)-3-formyl-2-hydroxy-4-methylhexanoyl]amino}cyclopropyl]-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C32 H43 N3 O6 | Definition date: | 2013-04-17 | Last modified: | 2013-04-17 |
|
 | PRD_001012 | Name: | Pyrrhocoricin | Formula: | C72 H120 N16 O18 | Definition date: | 2013-04-17 | Last modified: | 2013-04-17 |
|
 | PRD_001043 | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | Formula: | C14 H28 N2 O4 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|
 | PRD_000830 | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | Formula: | C35 H35 Br Cl N4 O10 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
 | PRD_000865 | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | Formula: | C31 H31 Br Cl N4 O6 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
 | PRD_000866 | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | Formula: | C29 H32 Br N4 O10 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|